Refiners Continue T...
Health Care: Drugs
Celsion Corporation (CLSN: NASDAQ)
$1.04 0.05 | 5.05%
05/24/13 - 01:10 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -26.57M | -23.22M | -18.82M | -15.20M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | -945.93K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 806.26K | 14.19M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -1.34M | -538.38K | 2.36M | 1.00M |
| (Decrease) Increase In Other Current Liabilities | -776.96K | -92.26K | 655.70K | -18.54K |
| (Increase) Decrease In Other Working Capital | 61.94K | 4.17K | 20.29K | 265.57K |
| Other Non-Cash Items | 5.42M | 1.32M | 1.10M | 45.71K |
| Net Cash From Continuing Operations | -22.33M | -22.74M | -13.37M | -930.33K |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -22.33M | -22.74M | -13.37M | -930.33K |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 6.93M |
| Purchases of Property, Plant & Equipment | -613.39K | -573.41K | -6.74K | -136.22K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | -8.50M |
| Other Cash from Investing Activities | 0.00 | -250.00K | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 1.66M | -11.09M | 5.21M | -1.70M |
| Issuance of Debt | 4.83M | 144.45K | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 10.80M | 52.41M | 0.00 | 0.00 |
| Repayment of Long-Term Debt | -110.29K | -142.43K | -108.33K | -234.74K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 428.34K | 2.48M | 6.33M |
| Net Cash From Financing Activities | 15.52M | 52.84M | 2.38M | 6.10M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -5.15M | 19.01M | -5.78M | 3.47M |
Portfolios with CLSN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- UserWatch
- UserBIO
- ContributorStocks Under-$10 Moving Hig...
- Contributor22 Biopharma Stocks With Br...
- ContributorTop 5 Small-Cap Stocks to C...
- ContributorStocks Under-$10 Moving Hig...
Latest CLSN Headlines from TheStreet
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- 4 Stocks Under $10 Spiking Higher 03.08.13 | 07:03 am
- Biotech Stock Mailbag: Northwest Bio, Amarin, Titan Pharma 02.15.13 | 06:02 am
- Ziopharm's Sarcoma Study And The Feuerstein-Ratain Rule 02.05.13 | 06:02 am
- Stocks Surge After January Jobs Report; Dow Eclipses 14,000 02.01.13 | 02:02 pm
- Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta 02.01.13 | 07:02 am
- Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocks 01.28.13 | 06:01 am
- Celsion Downgraded Right In Front of All-Important Study Results 01.17.13 | 06:01 am
- Biotech Stock Mailbag: Celsion Short Thesis, Hemispherx 12.14.12 | 06:12 am
- 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook 11.27.12 | 06:11 am
Press Releases for CLSN
- Celsion Announces Issuance Of Additional Patents Covering ThermoDox® Technologies - PR Newswire 05.22.13 | 08:05 am
- Celsion's ThermoDox® HEAT Study Findings Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) - PR Newswire 05.17.13 | 08:05 am
- Celsion Corporation To Hold First Quarter 2013 Financial Results Conference Call On Thursday, May 9, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Announces ThermoDox® HEAT Study Findings To Be Reviewed At The 9th Annual World Conference On Interventional Oncology (WCIO) In New York City On May 16, 2013 - PR Newswire 05.01.13 | 08:05 am
- Celsion Corporation Provides Business Update - PR Newswire 04.23.13 | 08:04 am
- Celsion Corporation To Hold Year-End 2012 Financial Results Conference Call On Monday, March 18, 2013 - PR Newswire 03.12.13 | 08:03 am
- Celsion Corporation Announces $15 Million Registered Direct Offering - PR Newswire 02.22.13 | 09:02 am
- Celsion Corporation Provides An Update Regarding ThermoDox® Agreements With Zhejiang HISUN Pharmaceutical Company For China - PR Newswire 02.05.13 | 06:02 pm
- Celsion Announces Results Of Phase III HEAT Study Of ThermoDox® In Primary Liver Cancer - PR Newswire 01.31.13 | 07:01 am
- Celsion Corporation To Host Conference Call And Webcast On January 31, 2013 At 8:00 AM EST To Present Top-Line Data From Its Pivotal Phase III HEAT Study - PR Newswire 01.30.13 | 04:01 pm
Partner Headlines for CLSN
- 3 Biotechs And The Feuerstein-Ratain Rule - Seeking Alpha 04.09.13 | 09:04 am
- A 2013 Diversified Bullish Portfolio In 10 Positions - Seeking Alpha 02.28.13 | 09:02 am
- After Phase III Failure, Celsion Is Still Worthless - Seeking Alpha 02.12.13 | 09:02 am
- Is Delcath The Post-Celsion Play On Liver Cancer? - Seeking Alpha 02.04.13 | 09:02 am
- Celsion Stock Blown Apart On Thermodox Phase III Data - Seeking Alpha 02.02.13 | 09:02 am
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- 5 Healthcare Companies With Recent Insider Buying - Seeking Alpha 11.18.12 | 09:11 am
- Pre-Market Earnings Report for November 12, 2012 : DHI, CYD, BZH, CLSN, RRST, CTIB - NASDAQ 11.09.12 | 09:11 pm
- 4 Biotechs That Just Got Mauled By Bears - Seeking Alpha 10.10.12 | 09:10 am
- Weekly CEO Buys Highlight: NIHD, RENT, VTNC, MDW - NASDAQ 09.24.12 | 02:09 pm
